Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1996 1
1998 1
1999 3
2000 2
2001 2
2008 1
2009 1
2011 1
2012 2
2013 1
2014 1
2015 2
2016 3
2017 1
2018 1
2019 2
2020 1
2021 3
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT).
Genta S, Lajkosz K, Yee NR, Spiliopoulou P, Heirali A, Hansen AR, Siu LL, Saibil S, Stayner LA, Yanekina M, Sauder MB, Keshavarzi S, Salawu A, Vornicova O, Butler MO, Bedard PL, Razak ARA, Rottapel R, Chruscinski A, Coburn B, Spreafico A. Genta S, et al. Among authors: chruscinski a. J Exp Clin Cancer Res. 2023 Oct 21;42(1):276. doi: 10.1186/s13046-023-02851-6. J Exp Clin Cancer Res. 2023. PMID: 37865776 Free PMC article.
Tankyrase represses autoinflammation through the attenuation of TLR2 signaling.
Matsumoto Y, Dimitriou ID, La Rose J, Lim M, Camilleri S, Law N, Adissu HA, Tong J, Moran MF, Chruscinski A, He F, Asano Y, Katsuyama T, Sada KE, Wada J, Rottapel R. Matsumoto Y, et al. Among authors: chruscinski a. J Clin Invest. 2022 Apr 1;132(7):e140869. doi: 10.1172/JCI140869. J Clin Invest. 2022. PMID: 35362478 Free PMC article.
Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients.
Hirzel C, Chruscinski A, Ferreira VH, L'Huillier AG, Natori Y, Han SH, Cordero E, Humar A, Kumar D; Influenza in Transplant Study Group. Hirzel C, et al. Among authors: chruscinski a. Am J Transplant. 2021 Aug;21(8):2709-2718. doi: 10.1111/ajt.16503. Epub 2021 Feb 18. Am J Transplant. 2021. PMID: 33484237 Free article.
Evaluation of a gene expression biomarker to identify operationally tolerant liver transplant recipients: the LITMUS trial.
Chruscinski A, Rojas-Luengas V, Moshkelgosha S, Issachar A, Luo J, Yowanto H, Lilly L, Smith R, Renner E, Zhang J, Epstein M, Grant D, McEvoy CM, Konvalinka A, Humar A, Adeyi O, Fischer S, Volmer FH, Taubert R, Jaeckel E, Juvet S, Selzner N, Levy GA. Chruscinski A, et al. Clin Exp Immunol. 2022 Jan 28;207(1):123-139. doi: 10.1093/cei/uxab011. Clin Exp Immunol. 2022. PMID: 35020854 Free PMC article. Clinical Trial.
Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis.
Appenzeller-Herzog C, Rosat A, Mathes T, Baroja-Mazo A, Chruscinski A, Feng S, Herrero I, Londono MC, Mazariegos G, Ohe H, Pons JA, Sanchez-Fueyo A, Waki K, Vionnet J. Appenzeller-Herzog C, et al. Among authors: chruscinski a. Liver Int. 2024 Jan;44(1):250-262. doi: 10.1111/liv.15764. Epub 2023 Oct 31. Liver Int. 2024. PMID: 37905605
Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center.
Ferreira VH, Chruscinski A, Kulasingam V, Pugh TJ, Dus T, Wouters B, Oza A, Ierullo M, Ku T, Majchrzak-Kita B, Humar ST, Bahinskaya I, Pinzon N, Zhang J, Heisler LE, Krzyzanowski PM, Lam B, Lungu IM, Manase D, Pace KM, Mashouri P, Brudno M, Garrels M, Mazzulli T, Cybulsky M, Humar A, Kumar D. Ferreira VH, et al. Among authors: chruscinski a. PLoS One. 2021 Feb 16;16(2):e0247258. doi: 10.1371/journal.pone.0247258. eCollection 2021. PLoS One. 2021. PMID: 33592074 Free PMC article.
Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection.
Clotet-Freixas S, Kotlyar M, McEvoy CM, Pastrello C, Rodríguez-Ramírez S, Farkona S, Cardinal H, Dieudé M, Hébert MJ, Li Y, Famure O, Chen P, Kim SJ, Chan E, Jurisica I, John R, Chruscinski A, Konvalinka A. Clotet-Freixas S, et al. Among authors: chruscinski a. Transplant Direct. 2021 Sep 20;7(10):e768. doi: 10.1097/TXD.0000000000001215. eCollection 2021 Oct. Transplant Direct. 2021. PMID: 34557585 Free PMC article.
Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study.
Chruscinski A, Juvet S, Moshkelgosha S, Renner E, Lilly L, Selzner N, Bredeson C, Grant D, Adeyi O, Fischer S, Demetris AJ, Zhang J, Epstein M, Macarthur M, Clement AM, Khalili K, Allan D, Altouri S, Bence-Bruckler I, Cattral M, Fulcher J, Galvin Z, Ghanekar A, Greig P, Huebsch L, Humar A, Kew A, Kekre N, Kim TK, McDiarmid S, Martin L, McGilvray I, Sabloff M, Sapisochin G, Selzner M, Smith R, Tinckam K, Yi TJ, Levy G, Atkins H. Chruscinski A, et al. Transplantation. 2022 Mar 1;106(3):562-574. doi: 10.1097/TP.0000000000003829. Transplantation. 2022. PMID: 34049362
41 results